Navigation Links
PET scans useful for some cancer treatment, but how do patients fare?
Date:11/12/2007

Positron emission tomography or PET scans can help clinicians diagnose and treat some cancers, but it is not clear yet whether the imaging technology helps people with cancer live longer and healthier lives, according to a comprehensive review by the U.K. National Health Service.

PET scans are one of the latest tools used to detect and determine a cancers activity in the body. PET is generally more accurate than other imaging technologies such as computerized tomography (CT) or magnetic resonance imaging (MRI) scans. Using tiny radioactive elements, a PET scan can zero in on the distinctive biochemical fingerprints that distinguish cancerous cells from normal tissue.

The most common type of PET scan, called FDG-PET, appears to lead to the best therapy for patients who have a newer diagnosis of non-small cell lung cancer and in those who have undergone treatment for Hodgkins lymphoma. FDG-PET can also help identify the best treatment for patients with colorectal cancer, and it can detect small, potentially malignant lung growths called solitary pulmonary nodules, say review authors led by Karen Facey.

For other cancers, PET can often improve the accuracy of detecting a tumor, but it is unclear how this affects a patients treatment and ultimately their outcome, said Facey, an evidence-based health policy researcher.

The most reliable evidence would suggest that FDG-PET is cost-effective [in the United Kingdom] in non-small cell lung cancer and Hodgkins lymphoma, she added.

Facey said this is the first comprehensive review of PET for determining how well patients are responding to chemotherapy and for determining the sites for radiation therapy.

It has identified many interesting new studies, but these are difficult to interpret given their different designs, so theres a real need for larger, better quality studies of this kind to be performed in the U.K., she said.

The review is published in the latest issue of Health Technology Assessment, the international journal series of the Health Technology Assessment programme, part of the National Institute for Health Research in the United Kingdom.

Facey and colleagues combed through the results of six systematic reviews and 158 primary studies that examined the effect of PET scans on the management of breast, colorectal, head and neck, lung, lymphoma, melanoma, esophageal and thyroid cancers.

For instance, did PET scans diagnose these cancers better than an MRI or CT scan" Could a PET scan give a better idea of a cancers severity or spread" Would they be better than other imaging techniques at detecting the recurrence of a cancer or monitoring a tumors response to treatment"

For many of the cancers examined in the review, the answers are still inconclusive and require larger, more careful study, the HTA authors found.

While research continues, physicians are already using combination PET/CT scans to help diagnose and treat cancer patients. Facey and colleagues also reviewed this new technology and say that the PET/CT scans appear to be slightly more accurate so far.

In September, the Society of Nuclear Medicine, whose members use PET technology, updated its scope of practice guidelines to reflect this trend.

Since many of the state-of-the-art nuclear medicine cameras as well as PET scanners have CT scanners attached to them, performing CT scans becomes one of the nuclear medicine technologists tasks, said Cindi Luckett-Gilbert, the chair of the societys special task force on the scope of practice.


'/>"/>

Contact: Lisa Esposito
hbns-editor@cfah.org
Center for the Advancement of Health
Source:Eurekalert

Related medicine news :

1. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
2. PET scans can accurately detect a breast tumors response to chemotherapy
3. High-tech CT scans: not a bad choice to test for clogged arteries
4. New Computerized Scans Effective for Spotting Clogged Arteries
5. Study suggests existing drugs may be useful in treating brain tumors
6. CAD plus MDCT useful in finding lung nodules
7. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
8. Survival differences by race most apparent in advanced stages of breast cancer
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. Pathway links inflammation, angiogenesis and breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their ... have been used to remove decayed dental matter, and that teeth were then filled ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... professor Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between ... relative proportion of young people involved in violence in the United States. The ...
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The adage ... Flex House, the next project in the company’s esteemed VISION House demonstration project series. ... use exactly the amount of resources they need to live affordably and abundantly without ...
(Date:4/21/2017)... ... 21, 2017 , ... The Hong Kong Polytechnic University (PolyU) launched today the ... education institutions in Hong Kong to support teaching, learning and research. It is also ... of facilities in Hong Kong. , With an area of 620 square metres ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
Breaking Medicine Technology: